Efficacy and Safety of Regorafenib Plus Immune Checkpoint Inhibitors with or Without TACE as a Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Xuegang Yang,1,2 Heping Deng,3 Yanyuan Sun,1 Yi Zhang,3 Yujie Lu,3 Guohui Xu,1,* Xiaoqi Huang2,* 1Department of Interventional Therapy, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Chengdu, People’s Republic of China; 2Huaxi MR Research Center (HMRRC), Functional and...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-02-01
|
Series: | Journal of Hepatocellular Carcinoma |
Subjects: | |
Online Access: | https://www.dovepress.com/efficacy-and-safety-of-regorafenib-plus-immune-checkpoint-inhibitors-w-peer-reviewed-fulltext-article-JHC |